Ocular Therapeutix, Inc.
Symbol: OCUL (NASDAQ)
11.38
▲ (0.35%) 0.040
Company Description:
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Key Stats
- Today's Open: $11.31
- Today's High: $11.51
- Today's Low: $11.31
- Today's Volume: 306.24K
- Yesterday Close: $11.34
- Yesterday High: $11.84
- Yesterday Low: $11.28
- Yesterday Volume: 1.90M
- Last Min Volume: 36
- Last Min High: $11.385
- Last Min Low: $11.38
- Last Min VWAP: $11.38297
Company Profile
- Name: Ocular Therapeutix, Inc.
- Website: https://www.ocutx.com
- Listed Date: 2014-07-25
- Location: BEDFORD, MA
- Market Status: Active
- CIK Number: 0001393434
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.49B
- Round Lot: 100
- Outstanding Shares: 211.90M
- Asset Type: CS
RECENT FILINGS FOR OCUL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-10 | 4 | View |
| 2025-10-08 | 144 | View |
| 2025-10-06 | 4 | View |
| 2025-10-06 | 4 | View |
| 2025-10-02 | 144 | View |
| 2025-10-02 | 144 | View |
| 2025-09-30 | 424B5 | View |
| 2025-09-30 | 8-K | View |
| 2025-09-30 | 8-K | View |
| 2025-09-30 | S-3ASR | View |
| 2025-09-11 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-27 | 4 | View |
| 2025-08-27 | 4 | View |
| 2025-08-27 | 4 | View |
| 2025-08-27 | 4 | View |
| 2025-08-25 | 144 | View |
| 2025-08-25 | 144 | View |
Latest News on OCUL